Selank for Sale: What a Listing Says Where a Label Would Be

Every Selank for sale page you will find is carrying a load it was not designed to carry. In a normal pharmaceutical transaction, the product page sells and the label informs. A dispensing label states the drug, the strength, the quantity, the lot, the expiry, the storage conditions, the pharmacy that dispensed it and the prescriber who authorised it. If any of that is wrong, several licensed parties are answerable.

Selank has no dispensing label anywhere in the United States, because it has no route to one. It is not FDA approved for any indication, it has no USP or NF monograph, and it does not appear on the 503A bulks list a compounding pharmacy would need to work from. So the listing is not marketing sitting alongside the real information. The listing is the information.

That reframing is the useful one, because it gives you a checklist that already exists. Take the fields a pharmacy label has to carry, ask which of them the listing in front of you supplies, and the good listings separate from the bad ones in about two minutes. We link a supplier at the end and earn a commission on sales through it, as set out in our affiliate disclosure, and we apply the same test to it.

The first field is what physical thing is in the box. Selank is sold in two formats and they are not variants of one product. A lyophilised vial contains freeze-dried powder, sealed under vacuum or inert gas, stable at room temperature for shipping and intended to be stored cold. A nasal spray contains a finished solution: peptide already dissolved into a carrier with a preservative system, filled into a bottle and assigned a shelf life.

A listing that does not say which one you are getting is failing at the first field. More often the failure is subtler: a listing shows a photograph of a spray bottle and describes purity data that belongs to raw powder. Those are two different products with two different risk profiles, and one certificate cannot cover both.

The reason to insist on the distinction is that every manufacturing question follows from it. Powder in a sealed vial has been through synthesis, purification and lyophilisation. A solution has been through all of that plus reconstitution, formulation, filling and sealing, usually by a party that is not a drug manufacturer and does not publish anything about those steps.

The second field is how much peptide is in the container. On a pharmacy label this is not a claim, it is a released specification, checked at manufacture and legally binding. On a research listing it is usually just a number on a page.

This is the field where one listing does something genuinely unusual, and it is the most instructive example in this whole cluster. Ascension Peptides publishes a certificate for Selank lot 29-01260229, issued by MZ Biolabs in Tucson on 7 February 2026, which reports a measured quantity of 12.29 mg per vial against a 10 mg label. Not the label figure repeated back. An assayed figure, roughly 23 percent above the stated strength, published as measured.

Two things make that worth crediting. The first is that most sellers do not quantify vial contents at all: they state the label strength and let you assume it. Quantifying it means running the assay and then publishing whatever it says, including a number that could have come out low. The second is that it is checkable. You can open the certificate for lot 29-01260229 and read the line yourself.

The caveat matters as much as the credit. That figure describes one lot. It is not a guarantee about the vial you receive, and treating a favourable assay on a February batch as a standing promise is exactly the mistake a certificate is meant to prevent. What it tells you is about the seller's practice, not about your vial. Your vial's number is on your vial's certificate, which is why lot matching is a separate check.

A pharmacy label carries a lot number because it is what connects a container in your hand to a batch record, a release test and, if necessary, a recall. Remove it and the rest of the label becomes decorative.

The same is true on a listing. A certificate without a lot number, or with a lot number that does not match the vial you were shipped, describes a batch that existed at some point and possibly not the one in the parcel. This is the single most common weakness in peptide listings: a well-formatted PDF, a laboratory name, a purity figure, and no way to tie any of it to your purchase.

So the check has two halves and both matter. Before you buy, confirm that the published certificate names a specific lot rather than describing the product in general. After the vial arrives, confirm that the number printed on it matches the number on the PDF. If a seller cannot produce a certificate for the lot they shipped, everything they published was about someone else's vial.

The same discipline is what separates listings in the adjacent peptide markets, which is why our piece on the BPC-157 formats a pharmacy would reject spends most of its length on the same field.

A dispensing label states storage conditions and a beyond-use date. Both are calculated rather than guessed, and both are the manufacturer's or pharmacy's responsibility. Research listings usually state neither, and when they do it is a general instruction rather than a product-specific one.

For a lyophilised peptide the honest position is that storage guidance is real and expiry is largely unestablished. Freeze-dried powder is shipped at ambient temperature and kept cold on arrival. A stated shelf life, by contrast, requires stability data generated over time under defined conditions, and that data does not exist publicly for research-grade Selank.

What a good listing does here is not invent a date. It states the format, states the storage condition, and does not pretend to a stability programme it has not run. A listing carrying a confident two-year expiry with no supporting data has told you something about its relationship with evidence generally.

We are deliberately not publishing handling or preparation instructions on this page. This is research material with no human-use route, and instructions for preparing it would contradict the legal basis on which every seller in the market lists it.

This is the field that decides whether a listing is worth anything, and it is the one FDA's stated concern points at directly. On its page covering bulk substances that may present significant safety risks, content current as of 22 April 2026, FDA writes that compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities, and that the agency lacks important information regarding any safety issues raised by selank acetate administered to humans.

Unpack that into tests. Peptide-related impurities are measured by purity assays, meaning HPLC with a chromatogram. Identity is confirmed by mass spectrometry against the expected mass, which for Selank is 751.43 daltons monoisotopic, consistent with the formula C33H57N11O9 and molecular weight 751.9 on its PubChem record. Aggregation and contamination risk, for anything that will be dissolved, are addressed by bacterial endotoxin testing and a sterility or microbial screen. That distinction between what a substance is and what else is in the container is the same one that runs through our piece on food-grade NAD+ powder reaching sterile IV bags.

The Ascension certificate covers the first two thoroughly. Purity is 99.32 percent by HPLC-UV with the chromatogram reproduced, showing the main peak at 7.13 minutes and a single minor peak at 6.36 minutes accounting for 0.68 percent. Identity is confirmed by mass spectrometry at a measured 751.47 daltons against an expected 751.43. That is a real analytical package, not a percentage on a graphic.

It does not cover the third. There is no endotoxin test, no LAL assay, no pyrogen test, no sterility screen and no heavy metals panel on that February document. Searching the PDF for any of those terms returns nothing.

The document worth finding is on the same product page. The certificate for batch 29-05260628, certified 2 June 2026 by Kovera Labs, does include a bacterial endotoxin analysis by kinetic chromogenic LAL to USP Chapter 85, reporting under 0.20 endotoxin units per millilitre against an acceptance limit of 0.5, plus a rapid sterility screen and an ICP-MS heavy metals panel. The vendor's Semax listing shows the same February-to-June change, so the scope belongs to a batch rather than to a product. The trap is that the clickable link on a listing is often the older, thinner PDF while the fuller one sits beside it as an image, so read every certificate on the page and ask which batch is being shipped.

The table below runs the fields a dispensing label must carry against what a research listing can offer, and what its absence costs you. It is the fastest way to see how much of the accountability structure is missing rather than merely relocated.

Note the pattern. The fields a listing can supply are the ones that describe the material. The fields it cannot supply are the ones that describe who is answerable. That is the actual difference between the two markets, and it does not close no matter how good the certificate is.

A listing that passes on every field it can control is worth taking seriously. Selank 10 mg from the supplier we link is $47.50, or $23.75 with the code PEPTIDEDECK, which is $2.38 per milligram. Quantity purchases of three, five or ten take 3, 5 or 10 percent off the list price; nothing published says the code combines with those tiers, so read them as alternatives. Free shipping starts at $250 and dispatch is same day before 2pm CST.

The remaining work is on your side and it takes ten minutes. Open the certificate before you buy and confirm it names a lot. Confirm purity is shown as a chromatogram, not a number. Confirm the measured mass lands near 751.4. Then ask, in writing, which batch is being shipped to you and read that batch's certificate, because the February document has no endotoxin data and the June one does. A seller who answers that question directly has told you something useful either way.

If you want the criteria applied to suppliers rather than to listings, our ranking method for Selank sources weights them explicitly. If you want the regulatory position in full, our page on the legal status is the careful one, and our scam checker runs a version of this logic against any specific offer you are looking at.